Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — Subchondral bone lesions can usually be managed nonoperatively. However, once collapse occurs ...

Please provide your email address to receive an email when new articles are posted on . Research linking fluctuations in bone marrow lesions with pain fluctuations may suggest that targeting these ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients. These ...

Eosinophilic granuloma (EG) is a type of lesion that usually appears on bones. These lesions are caused by an overgrowth of Langerhans cells, which are naturally occurring white blood cells that are ...

Cochran-Mantel-Haenszel test with modified ridit score. Up to month 25; comparison with pamidronate. Up to month 24; comparison with placebo. Up to month 21; comparison with placebo. This is an ASCO ...

Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its ...

SYRACUSE, N.Y.--(BUSINESS WIRE)--Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and ...

FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab is the first and only treatment to demonstrate a dramatic ...

Patients with midfoot pain and MRI-detected bone marrow lesions who wore firm foot orthoses achieved greater reductions in pain and bone marrow lesion volume over 12 weeks than those who wore ...

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma Teriparatide treatment was associated with an improved rate of resolution of established MRONJ ...